Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal bevacizumab alone or with dexamethasone for diabetic macular edema
IRCT20220328054362N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of bevacizumab and dexamethasone in diabetic macular edema (DME) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started Feb 2019; status: completed.
02
Drugs
bevacizumabdexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on IRCT20220328054362N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220328054362N1.